We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

35 hedge funds and large institutions have $63.8M invested in Astria Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

47.39% more ownership

Funds ownership: 8.83% → 56.22% (+47%)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

26% less capital invested

Capital invested by funds: $85.6M → $63.8M (-$21.9M)

26% less call options, than puts

Call options by funds: $262K | Put options by funds: $354K

40% less funds holding

Funds holding: 58 → 35 (-23)

82% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 28

Holders
35
Holders Change
-23
Holders Change %
-39.66%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
14
Closed
28
Calls
$262K
Puts
$354K
Net Calls
-$92K
Net Calls Change
-$71K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$6.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.01M
3
RCM
RA Capital Management
Massachusetts
+$2.6M
4
FFM
Fairmount Funds Management
Pennsylvania
+$2.2M
5
Renaissance Technologies
Renaissance Technologies
New York
+$445K

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$6.73M
2
BC
Boxer Capital
California
-$3.75M
3
ACP
Acuta Capital Partners
California
-$2.48M
4
Millennium Management
Millennium Management
New York
-$974K
5
CAM
Cormorant Asset Management
Massachusetts
-$371K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$28K -$172K -17,922 -85%
UBS Group
27
UBS Group
Switzerland
$27K +$28.8K +3,008 New
Bank of America
28
Bank of America
North Carolina
$11K +$10K +1,046 +453%
BFEC
29
Benjamin F. Edwards & Company
Missouri
$3K – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$1K -$2.43K -254 -80%
Wells Fargo
31
Wells Fargo
California
$1K -$498 -52 -48%
CG
32
Cutler Group
California
$1K -$10 -1 -0.9%
Federated Hermes
33
Federated Hermes
Pennsylvania
$1K -$10 -1 -3%
KFI
34
Key Financial Inc
Pennsylvania
$1K -$10 -1 -1%
Osaic Holdings
35
Osaic Holdings
Arizona
$1K – – –
LGM
36
Logos Global Management
California
– -$6.73M -531,667 Closed
BC
37
Boxer Capital
California
– -$3.75M -295,833 Closed
ACP
38
Acuta Capital Partners
California
– -$2.48M -195,612 Closed
Millennium Management
39
Millennium Management
New York
– -$974K -76,935 Closed
SCM
40
Silverarc Capital Management
Massachusetts
– -$398 -31,463 Closed
TEE
41
Tibra Equities Europe
United Kingdom
– -$328K -25,883 Closed
PPA
42
Parametric Portfolio Associates
Washington
– -$243K -19,178 Closed
E
43
Ergoteles
New York
– -$193K -15,217 Closed
Group One Trading
44
Group One Trading
Illinois
– -$136K -14,201 Closed
BFM
45
Boothbay Fund Management
New York
– -$177K -14,000 Closed
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
– -$130K -10,241 Closed
State Street
47
State Street
Massachusetts
– -$120K -9,500 Closed
CCP
48
Corient Capital Partners
California
– -$117K -9,222 Closed
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
– -$80.3K -8,379 Closed
Two Sigma Advisers
50
Two Sigma Advisers
New York
– -$76K -6,033 Closed
1
2
3

ATXS Hedge Fund Activity: Q3 2021 in Review

35 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q3 2021, worth a combined $63.8M — down 26% from $85.6M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ATXS and 5 opened new positions — a net loss of 23 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Perceptive Advisors, adding an estimated $6.5M. The largest seller was Logos Global Management, exiting entirely with an estimated $6.73M sold.

  • 35 institutional investors held Astria Therapeutics (ATXS) as of Q3 2021, down from 58 in Q2 2021.
  • Funds reported $63.8M of Astria Therapeutics stock for Q3 2021, down 26% quarter-over-quarter.
  • 5 funds opened new Astria Therapeutics positions in Q3 2021 and 28 closed out, a net change of -23 holders.
  • The largest Astria Therapeutics buyer in Q3 2021 was Perceptive Advisors, an estimated $6.5M added.
  • The largest Astria Therapeutics seller in Q3 2021 was Logos Global Management, an estimated $6.73M sold.

Based on aggregated 13F filings for Q3 2021.